Last Updated: May 10, 2026

Profile for European Patent Office Patent: 1919458

✉ Email this page to a colleague

Supplementary Protection Certificates for European Patent Office Patent: 1919458

Country	SPC	SPC Expiration
Netherlands	C300649	⤷ Start Trial
Denmark	CR 2014 00013	⤷ Start Trial
Slovakia	194 50001-2014	⤷ Start Trial
Austria	19/2014	⤷ Start Trial
Netherlands	300649	⤷ Start Trial
Germany	122014000023	⤷ Start Trial
Belgium	2014C/018	⤷ Start Trial

US Patent Family Members and Approved Drugs for European Patent Office Patent: 1919458

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.

Glossary

Subscribe to access the full database, or Start Trial
US Patent Number	US Expiration Date	US Applicant	US Tradename	Generic Name
8,026,284	Mar 22, 2028	Horizon	PROCYSBI	cysteamine bitartrate
9,192,590	Jul 26, 2027	Horizon	PROCYSBI	cysteamine bitartrate
9,198,882	Jul 26, 2027	Horizon	PROCYSBI	cysteamine bitartrate
9,925,156	Jul 26, 2027	Horizon	PROCYSBI	cysteamine bitartrate
9,925,157	Jul 26, 2027	Horizon	PROCYSBI	cysteamine bitartrate
9,925,158	Jul 26, 2027	Horizon	PROCYSBI	cysteamine bitartrate
>US Patent Number	>US Expiration Date	>US Applicant	>US Tradename	>Generic Name

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.